A recent report from the Research Consortium for Health Care Value Assessment found that annual spending on five low-value services under private plans hit $3 billion in 2015, the American Journal of Managed Care (AJMC) reports.
“Our findings suggest that even though there has been significant discussion on reducing low-value care services in the system, to-date, the reduction has been relatively modest,” Altarum Senior Analyst and lead author Corwin Rhyan said in a statement. “However, the increase in spending on the selected high-value services is a positive indicator and presents an opportunity for future measurement and analysis.”
Below are the five low-value services analyzed in the report, per AJMC’s report:
- Vitamin D screening tests;
- Prostate-specific antigen screening in men over age 75;
- Unneeded testing and laboratory work prior to low-risk surgery;
- Imaging for uncomplicated low-back pain within the first six weeks of diagnosis; and
- Use of more expensive brand name medications when generics with identical active ingredients are available.
To read the full report on AJMC, click here.